| HGNC Family | Tropomyosins (TPM) |
| Name | tropomyosin 2 (beta) |
| Description | This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTPM2, which encodes the β‐tropomyosin isoform, is an essential component of the thin filament in striated muscle where it binds along actin filaments and regulates actin–myosin interactions in a Ca²⁺‐dependent fashion. In normal muscle, proper head‐to‐tail polymerization of TPM2 not only helps stabilize the actin filament but also fine‐tunes the formation and cycling of myosin cross-bridges to enable effective force generation. Several studies have demonstrated that specific TPM2 mutations disrupt its affinity for actin, alter Ca²⁺ sensitivity and affect cross-bridge kinetics—phenomena that manifest in a spectrum of congenital myopathies (including nemaline myopathy, cap disease, congenital fibre type disproportion, and distal arthrogryposis) as well as in clinical conditions such as Escobar syndrome. In patients, mutant TPM2 proteins show impaired incorporation into the sarcomere, disturbances in cooperative thin filament activation, and defects in the head-to-tail interactions that normally underlie muscle contraction and stability. These defect(s) thereby lead to either hypercontractile or hypocontractile phenotypes depending on the specific amino acid change and its impact on structural dynamics and actomyosin regulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in muscle, TPM2 also contributes importantly to the regulation and stabilization of the actin cytoskeleton in non‐muscle cells. Alterations in TPM2 expression have been linked to changes in cellular rigidity, stress fiber organization, and intracellular transport. For example, TPM2 helps modulate local contractile events for rigidity sensing on the extracellular matrix as well as the initiation and termination of motor protein–driven runs along microtubules. Moreover, aberrant TPM2 expression or splicing is emerging as a potential biomarker in various cancers—including ovarian, prostate, breast, and glioblastoma—as well as in other pathological contexts such as atherosclerosis and neuroendocrine tumors. In these settings, dysregulation of TPM2 is thought to impact cell proliferation, migration, and epithelial–mesenchymal transition by altering cytoskeletal dynamics and cellular adhesion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alain Expert-Bezançon, Alain Sureau, Patrice Durosay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M405377200"}], "href": "https://doi.org/10.1074/jbc.M405377200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15208309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15208309"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Tajsharghi, E Kimber, D Holmgren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distal arthrogryposis and muscle weakness associated with a beta-tropomyosin mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000256339.40667.fb"}], "href": "https://doi.org/10.1212/01.wnl.0000256339.40667.fb"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17339586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17339586"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Homa Tajsharghi, Monica Ohlsson, Christopher Lindberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Neurol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/archneur.64.9.1334"}], "href": "https://doi.org/10.1001/archneur.64.9.1334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17846275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17846275"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "J Nilsson, H Tajsharghi "}, {"type": "b", "children": [{"type": "t", "text": "Beta-tropomyosin mutations alter tropomyosin isoform composition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1468-1331.2008.02131.x"}], "href": "https://doi.org/10.1111/j.1468-1331.2008.02131.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18422639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18422639"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Nicole Monnier, Joel Lunardi, Isabelle Marty, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Absence of beta-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2008.11.009"}], "href": "https://doi.org/10.1016/j.nmd.2008.11.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19155175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19155175"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ilya Nevzorov, Charles Redwood, Dmitrii Levitsky "}, {"type": "b", "children": [{"type": "t", "text": "Stability of two beta-tropomyosin isoforms: effects of mutation Arg91Gly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Muscle Res Cell Motil (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10974-009-9171-3"}], "href": "https://doi.org/10.1007/s10974-009-9171-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19214762"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19214762"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nigel F Clarke, Ana Domazetovska, Leigh Waddell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cap disease due to mutation of the beta-tropomyosin gene (TPM2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2009.03.003"}], "href": "https://doi.org/10.1016/j.nmd.2009.03.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19345583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19345583"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Julien Ochala, Hiroyuki Iwamoto, Lars Larsson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A myopathy-linked tropomyosin mutation severely alters thin filament conformational changes during activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1001733107"}], "href": "https://doi.org/10.1073/pnas.1001733107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20457903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20457903"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Minttu Marttila, Elina Lemola, William Wallefeld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20111030"}], "href": "https://doi.org/10.1042/BJ20111030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22084935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22084935"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "H Tajsharghi, M Ohlsson, L Palm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myopathies associated with β-tropomyosin mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2012.05.018"}], "href": "https://doi.org/10.1016/j.nmd.2012.05.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22749895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22749895"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Julien Ochala, David S Gokhin, Isabelle Pénisson-Besnier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/dds289"}], "href": "https://doi.org/10.1093/hmg/dds289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22798622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22798622"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mohamed Jarraya, Susana Quijano-Roy, Nicole Monnier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2012.06.347"}], "href": "https://doi.org/10.1016/j.nmd.2012.06.347"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22980765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22980765"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ann E Davidson, Fazeel M Siddiqui, Michael A Lopez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/aws344"}], "href": "https://doi.org/10.1093/brain/aws344"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23413262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23413262"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jung Min Ko, In-Ho Choi, Goo-Hyun Baek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "First Korean family with a mutation in TPM2 associated with Sheldon-Hall syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Korean Med Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3346/jkms.2013.28.5.780"}], "href": "https://doi.org/10.3346/jkms.2013.28.5.780"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23678273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23678273"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Olga E Karpicheva, Paul Robinson, Adam Piers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The nemaline myopathy-causing E117K mutation in β-tropomyosin reduces thin filament activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2013.05.001"}], "href": "https://doi.org/10.1016/j.abb.2013.05.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23689010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23689010"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Saba Abdul-Hussein, Karin Rahl, Ali-Reza Moslemi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phenotypes of myopathy-related beta-tropomyosin mutants in human and mouse tissue cultures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0072396"}], "href": "https://doi.org/10.1371/journal.pone.0072396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24039757"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24039757"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Gülsenay Citirak, Nanna Witting, Morten Duno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2013.12.008"}], "href": "https://doi.org/10.1016/j.nmd.2013.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24507666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24507666"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Olga E Karpicheva, Charles S Redwood, Yurii S Borovikov "}, {"type": "b", "children": [{"type": "t", "text": "The E117K mutation in β-tropomyosin disturbs concerted conformational changes of actomyosin in muscle fibers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2014.03.007"}], "href": "https://doi.org/10.1016/j.abb.2014.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24657080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24657080"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Minttu Marttila, Vilma-Lotta Lehtokari, Steven Marston, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.22554"}], "href": "https://doi.org/10.1002/humu.22554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24692096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24692096"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Olga E Karpicheva, Armen O Simonyan, Nadezhda V Kuleva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbapap.2015.12.004"}], "href": "https://doi.org/10.1016/j.bbapap.2015.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26708479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26708479"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Katelyn S Weymouth, Susan H Blanton, Tamar Powell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional Assessment of Clubfoot Associated HOXA9, TPM1, and TPM2 Variants Suggests a Potential Gene Regulation Mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Orthop Relat Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11999-016-4788-1"}], "href": "https://doi.org/10.1007/s11999-016-4788-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27020427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27020427"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shan Li, Yi You, Jinsong Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel mutations in TPM2 and PIEZO2 are responsible for distal arthrogryposis (DA) 2B and mild DA in two Chinese families."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12881-018-0692-8"}], "href": "https://doi.org/10.1186/s12881-018-0692-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30285720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30285720"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Alexander M Matyushenko, Daniil V Shchepkin, Denis S Susorov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and functional properties of αβ-heterodimers of tropomyosin with myopathic mutations Q147P and K49del in the β-chain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.12.019"}], "href": "https://doi.org/10.1016/j.bbrc.2018.12.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30545627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30545627"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Julie Vogt, Atif Al-Saedi, Tracey Willis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A recurrent pathogenic variant in TPM2 reveals further phenotypic and genetic heterogeneity in multiple pterygium syndrome-related disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.13728"}], "href": "https://doi.org/10.1111/cge.13728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32092148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32092148"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Małgorzata Śliwinska, Katarzyna Robaszkiewicz, Piotr Wasąg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations Q93H and E97K in "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "TPM2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Disrupt Ca-Dependent Regulation of Actin Filaments."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22084036"}], "href": "https://doi.org/10.3390/ijms22084036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33919826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33919826"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Stephen J Assinder, Edith Au, Qihan Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20626"}], "href": "https://doi.org/10.1002/mc.20626"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20336778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20336778"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Eri Kubo, Nailia Hasanova, Nigar Fatma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated tropomyosin expression is associated with epithelial-mesenchymal transition of lens epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1582-4934.2012.01654.x"}], "href": "https://doi.org/10.1111/j.1582-4934.2012.01654.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23205574"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23205574"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Betsy B McIntosh, Erika L F Holzbaur, E Michael Ostap "}, {"type": "b", "children": [{"type": "t", "text": "Control of the initiation and termination of kinesin-1-driven transport by myosin-Ic and nonmuscle tropomyosin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cub.2014.12.008"}], "href": "https://doi.org/10.1016/j.cub.2014.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25660542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25660542"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Haguy Wolfenson, Giovanni Meacci, Shuaimin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tropomyosin controls sarcomere-like contractions for rigidity sensing and suppressing growth on soft matrices."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb3277"}], "href": "https://doi.org/10.1038/ncb3277"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26619148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26619148"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Syamalima Dube, Anish Thomas, Lynn Abbott, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.4732"}], "href": "https://doi.org/10.3892/or.2016.4732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27108600"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27108600"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Eri Kubo, Shinsuke Shibata, Teppei Shibata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13030"}], "href": "https://doi.org/10.1111/jcmm.13030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27976512"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27976512"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jinfeng Zhang, Jian Zhang, Shouping Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000487162"}], "href": "https://doi.org/10.1159/000487162"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29414807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29414807"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Camilla B Mitchell, Bronte Black, Faith Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-018-03049-z"}], "href": "https://doi.org/10.1007/s11060-018-03049-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30535593"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30535593"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Christophe Couderc, Julien Bollard, Yohann Couté, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanisms of local invasion in enteroendocrine tumors: identification of novel candidate cytoskeleton-associated proteins in an experimental mouse model by a proteomic approach and validation in human tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2014.09.006"}], "href": "https://doi.org/10.1016/j.mce.2014.09.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25224486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25224486"}]}]}]}
|
| Synonyms | TMSB, NEM4, AMCD1, HEL-S-273, DA1 |
| Proteins | TPM2_HUMAN |
| NCBI Gene ID | 7169 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TPM2 has 11,373 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 130 datasets.
Click the + buttons to view associations for TPM2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by TPM2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TPM2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TPM2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TPM2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TPM2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TPM2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TPM2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TPM2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TPM2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TPM2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TPM2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TPM2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with TPM2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TPM2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TPM2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TPM2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TPM2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TPM2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TPM2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TPM2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TPM2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TPM2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TPM2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TPM2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving TPM2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving TPM2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TPM2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TPM2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TPM2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TPM2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TPM2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TPM2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TPM2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TPM2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TPM2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TPM2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TPM2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TPM2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TPM2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TPM2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TPM2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TPM2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TPM2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TPM2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TPM2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TPM2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TPM2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TPM2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TPM2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing TPM2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TPM2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TPM2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TPM2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TPM2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TPM2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TPM2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TPM2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TPM2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TPM2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for TPM2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TPM2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with TPM2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TPM2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with TPM2 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with TPM2 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with TPM2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TPM2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TPM2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TPM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TPM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TPM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate TPM2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways 2026 | pathways involving TPM2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TPM2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TPM2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TPM2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TPM2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TPM2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TPM2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TPM2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TPM2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TPM2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TPM2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TPM2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TPM2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TPM2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TPM2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing TPM2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| NURSA Protein-Protein Interactions | interacting proteins for TPM2 from the NURSA Protein-Protein Interactions dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with TPM2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TPM2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TPM2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TPM2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TPM2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TPM2 protein from the Wikipathways PFOCR 2024 dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of TPM2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving TPM2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TPM2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TPM2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TPM2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TPM2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TPM2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TPM2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TPM2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with TPM2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TPM2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TPM2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of TPM2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TPM2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TPM2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TPM2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TPM2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TPM2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TPM2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TPM2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TPM2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TPM2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TPM2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TPM2 protein from the WikiPathways Pathways 2024 dataset. | |